Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Mar 24, 2022 · 10-K · 83 days after period end · 0001493152-22-007664
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$2.29M | -$4.41M | -$3.60M | -$2.76M |
| EPS Diluted | — | -$0.04 | -$0.08 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 24, 2022 · 83 d after period end
